SELLAS Life Sciences Group, Inc.

SLS ·Healthcare, Drug Manufacturers - General, United States
Financial Statements SEC Filings

SEC Filings

Form Filed Description
8-K Aug 11, 2026 8-K
10-Q Aug 11, 2026 10-Q
SCHEDULE 13G Aug 7, 2026
SCHEDULE 13G Jul 31, 2026
8-K Jul 27, 2026 FORM 8-K
8-K Jun 25, 2026 FORM 8-K
8-K Jun 18, 2026 FORM 8-K
4 Jun 18, 2026 OWNERSHIP DOCUMENT
S-8 Jun 16, 2026 FORM S-8
8-K Jun 2, 2026 FORM 8-K
8-K May 12, 2026 8-K
10-Q May 12, 2026 10-Q
SCHEDULE 13G/A Apr 24, 2026
ARS Apr 23, 2026 ARS
DEFA14A Apr 23, 2026 DEFA14A
DEF 14A Apr 23, 2026 FORM- DEF 14A
SCHEDULE 13G/A Mar 27, 2026
S-3ASR Mar 20, 2026 S-3ASR
8-K Mar 19, 2026 8-K
10-K Mar 19, 2026 10-K
8-K Mar 11, 2026 FORM 8-K
SCHEDULE 13G/A Feb 17, 2026
SCHEDULE 13G/A Jan 30, 2026
4 Jan 9, 2026 OWNERSHIP DOCUMENT
4 Jan 9, 2026 OWNERSHIP DOCUMENT
← Newer Page 1 of 51 · 1272 filings Older →